Last update: Nov. 16, 2018
Minimal risk for breastfeeding and infant.
Intravenous administration, every 6 to 8 hours.
Like other beta-lactams, it is excreted in breast milk in a clinically insignificant amount (Matsuda 1988, Ito 1988).
Its practically no oral bioavailability would make it difficult for the infant to pass through the breast milk ingested, except in preterm infants and an immediate neonatal period in which there may be increased intestinal permeability.
Medication of authorized use in infants and neonates (Merck 2016).
The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora (Benyamini 2005, Ito 1993, Kafetzis 1981).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM